CAZZANIGA, GIOVANNI

CAZZANIGA, GIOVANNI  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 269 (tempo di esecuzione: 0.043 secondi).
Titolo Tipologia Data di pubblicazione Autori File
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Idiopathic erythrocytosis: a germline disease? 01 - Articolo su rivista 2024 Elli, E. M.Mauri, M.D’Aliberti, D.Crespiatico, I.Fontana, D.Redaelli, S.Pelucchi, S.Spinelli, S.Manghisi, B.Cavalca, F.Aroldi, A.Ripamonti, A.Palamini, S.Mottadelli, F.Massimino, L.Ramazzotti, D.Cazzaniga, G.Piperno, A.Gambacorti-Passerini, C.Piazza, R. +
Antibody Deficiency in Patients with Biallelic KARS1 Mutations 01 - Articolo su rivista 2023 Saettini F.Guerra F.Fazio G.Ardissone A.Quadri M.Mauri M.Piazza R.Cazzaniga G.Biondi A. +
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica] 01 - Articolo su rivista 2023 Bettini L. R.Lauriola R. S.Coliva T.Biondi A.Cazzaniga G. +
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7) 99 - Altro 2023 Saettini F.Guerra F.Fazio G.Ardissone A.Romano R.Quadri M.Gasperini S.Mauri M.Piazza R.Cazzaniga G.Biondi A. +
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial 01 - Articolo su rivista 2023 Valsecchi M. G.Cazzaniga G.Biondi A. +
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2023 Oikonomou A.Saitta C.Valsecchi M. G.Biondi A.Cazzaniga G. +
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 01 - Articolo su rivista 2023 Barone, COrsenigo, RCazzola, APatelli, AQuattrini, GVergani, BBombelli, SDe Marco, SD'Orlando, CBianchi, CLeone, BMeneveri, RBiondi, ACazzaniga, GBrunelli, SAzzoni, E +
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2023 Oikonomou, AValsecchi, LQuadri, MProcopio, SSavino, A. MValsecchi, M. GBiondi, ACazzaniga, GPalmi, C +
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 01 - Articolo su rivista 2023 Nucera S.Fazio G.Pagani R.Rambaldi A.Valsecchi M. G.Biondi A.Cazzaniga G. +
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement 01 - Articolo su rivista 2023 Cazzaniga, Giovanni +
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome 01 - Articolo su rivista 2022 Saettini, FrancescoColiva, Tiziana AngelaGalbiati, MartaCazzaniga, GiovanniBiondi, Andrea +
Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse 01 - Articolo su rivista 2022 Cazzaniga G. +
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia 01 - Articolo su rivista 2022 Cazzaniga G. +
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2022 D'Angiò, MariellaCazzaniga, GiovanniFazio, Grazia +
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 01 - Articolo su rivista 2022 Biondi, AndreaValsecchi, Maria GraziaRizzari, CarmeloConter, ValentinoCazzaniga, Giovanni +
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis 01 - Articolo su rivista 2022 Fumagalli, MonicaCazzaniga, GiovanniFazio, Grazia +
Identical EP300 variant leading to Rubinstein–Taybi syndrome with different clinical and immunologic phenotype 01 - Articolo su rivista 2022 Saettini F.Fazio G.Cazzaniga G.Biondi A. +
Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR 03 - Contributo in libro 2022 Cazzaniga, G +
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol 01 - Articolo su rivista 2022 Biondi A.Cazzaniga G.Valsecchi M. G. +